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IMPORTANCE Neonates born to overweight or obese women are larger and at higher risk of
birth complications. Manymaternal obesity-related traits are observationally associated with
birth weight, but the causal nature of these associations is uncertain.
OBJECTIVE To test for genetic evidence of causal associations of maternal bodymass index
(BMI) and related traits with birth weight.
DESIGN, SETTING, AND PARTICIPANTS Mendelian randomization to test whethermaternal BMI
and obesity-related traits are potentially causally related to offspring birth weight. Data from
30487 women in 18 studies were analyzed. Participants were of European ancestry from
population- or community-based studies in Europe, North America, or Australia and were part
of the Early Growth Genetics Consortium. Live, term, singleton offspring born between 1929
and 2013 were included.
EXPOSURES Genetic scores for BMI, fasting glucose level, type 2 diabetes, systolic blood
pressure (SBP), triglyceride level, high-density lipoprotein cholesterol (HDL-C) level, vitamin
D status, and adiponectin level.
MAIN OUTCOME ANDMEASURE Offspring birth weight from 18 studies.
RESULTS Among the 30487 newborns themean birth weight in the various cohorts ranged
from 3325 g to 3679 g. Thematernal genetic score for BMI was associated with a 2-g (95% CI,
0 to 3 g) higher offspring birth weight per maternal BMI-raising allele (P = .008). The
maternal genetic scores for fasting glucose and SBPwere also associated with birth weight
with effect sizes of 8 g (95% CI, 6 to 10 g) per glucose-raising allele (P = 7 × 10−14) and −4 g
(95% CI, −6 to −2g) per SBP-raising allele (P = 1×10−5), respectively. A 1-SD ( ≈ 4 points)
genetically higher maternal BMI was associated with a 55-g higher offspring birth weight
(95% CI, 17 to 93 g). A 1-SD ( ≈ 7.2 mg/dL) genetically higher maternal fasting glucose
concentration was associated with 114-g higher offspring birth weight (95% CI, 80 to 147 g).
However, a 1-SD ( ≈ 10mmHg) genetically higher maternal SBP was associated with a 208-g
lower offspring birth weight (95% CI, −394 to −21 g). For BMI and fasting glucose, genetic
associations were consistent with the observational associations, but for systolic blood
pressure, the genetic and observational associations were in opposite directions.
CONCLUSIONS AND RELEVANCE In this mendelian randomization study, genetically elevated
maternal BMI and blood glucose levels were potentially causally associated with higher
offspring birth weight, whereas genetically elevatedmaternal SBP was potentially causally
related to lower birth weight. If replicated, these findings may have implications for
counseling andmanaging pregnancies to avoid adverse weight-related birth outcomes.
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N eonates born tooverweight or obesewomenaremorelikely to be large for gestational age.1 The precisemechanisms underlying this association and the ex-
tent to which confounding factors contribute are poorly un-
derstood. It is important to understandwhichmaternal traits
are causally associatedwith birthweight because thismay fa-
cilitate targeted development of interventions to be tested in
randomizedclinical trialsandenableclear, evidence-basedrec-
ommendations for pregnant women.
Maternal overweight and obesity are key risk factors for
gestationaldiabetes.2Even intheabsenceofdiabetesandwhen
following the same controlleddiet, obesewomenhavehigher
glucose levels than normal-weight women.3 The association
between gestational diabetes and higher birth weight is well
documented.4 Maternal glucose levels below those diagnos-
ticofdiabetesalsoshowstrongassociationswithbirthweight.5
The fetus of an overweight or obese woman may be
exposed to the consequences of higher maternal triglyceride
levels and blood pressure, lower levels of high-density lipo-
protein cholesterol (HDL-C) and adiponectin, and lower vita-
min D status (Box 1).1,6,7 However, associations are not always
consistently observed and may be confounded by maternal
socioeconomic status and associated behaviors such as
smoking and diet. Furthermore, the high intercorrelation of
obesity-related traits complicates determination of causal
relationships in an observational setting.
Maternal genotypes may be used in a mendelian
randomization13,14 approach to provide evidence of a poten-
tial causal association betweenmaternal traits and birth out-
comes (Figure 1). Mendelian randomization is analogous to a
randomized clinical trial: genotypes, which are randomly al-
located at conception, are largely free from confounding and
can be used to estimate the possible causal effects of mater-
nal traits. In this study, genetic variants were selected to cal-
culate genetic scores representingmaternal bodymass index
(BMI; calculated as weight in kilograms divided by height in
meters squared) and each of 7 obesity-relatedmaternal traits.
The potential causal relationship betweenmaternal BMI and
each related trait was estimated by testing associations be-
tweenmaternal genetic risk scoresandoffspringbirthweights.
Methods
Study Participants
Single-nucleotide polymorphism (SNP) genotype data were
used from 30487 women participating in 18 population- or
community-based studies in Europe, North America, or
Australia. The birth weight of 1 child per mother was
included (see eTable 1 for full details of participant charac-
teristics and eTable 2 for genotyping information, both in
the Supplement). Birth weight was measured by trained
study personnel (n = 2 studies), from medical records
(n = 10 studies), or from maternal report (n = 6 studies). The
offspring years of birth were from 1929 to 2013. Multiple
births, stillbirths, congenital anomalies, births before 37
weeks’ gestation, and individuals of non-European ancestry
were excluded. Informed consent was obtained from all par-
ticipants, and study protocols were approved by the local,
regional, or institutional ethics committees.
Selection ofMaternal Obesity-Related Traits and SNPs
Inaddition toBMI, traitswere selected that areassociatedwith
maternal obesity andmay affect fetal growth through the in-
trauterine environment. Their effectsweremodeled in thedi-
rections hypothesized by their relationships tomaternal BMI
(Box 1).
Single-nucleotidepolymorphismsknowntoberobustlyas-
sociated (P < 5 × 10−8)withBMI andeachobesity-related trait
were selected. Full details of the selected SNPs are provided
in eTable 3 in the Supplement. Single-nucleotide polymor-
phismsassociatedwithfastingglucoseandtype2diabeteswere
used to representmaternal glycemia.The type2diabetes SNPs
were considered to represent exposure to maternal diabetes
inpregnancy, includinggestationaldiabetes, givenoverlapbe-
tween type 2 and gestational diabetes’ genetic susceptibility
variants.15 For bloodpressure, SNPswere selected that arepri-
marily associated with systolic blood pressure (SBP), al-
though all also show strong evidence of associationwith dia-
stolic blood pressure. For vitamin D status, 2 SNPs with
hypothesized roles in vitamin D synthesis were used to rep-
resent 25(OH)D levels (an indicator of overall vitamin D sta-
tus), as previously recommended.16,17 Further details of SNP
selection are provided in the eMethods in the Supplement.
A weighted genetic score was calculated for each mater-
nal trait (seeeMethods in theSupplement for full details). Very
few of the selected SNPs have been tested in pregnancy. Ge-
netic scoreswere validated by confirming that eachwas asso-
ciatedwith its respectivematernal trait,measuredduringpreg-
nancy (with the exceptionofBMI, forwhich theprepregnancy
value was used). Maternal prepregnancy BMI was available
from registry data (n = 2 studies) or calculated from self-
reported weight and height (n = 3 studies). In the Avon Lon-
gitudinal Study of Parents and Children (ALSPAC) study, the
self-report was validated with a clinic measure.18 Details of
Box 1. Maternal Traits ThatMay Affect Her Fetus
Maternal Traits Hypothesized to Increase Fetal Growth
Higher bodymass index
Higher fasting glucose
Gestational or type 2 diabetes
Higher triglycerides
Lower high-density lipoprotein cholesterol
Lower adiponectin
Maternal Traits Hypothesized to Decrease Fetal Growth
High blood pressure
Lower vitamin D status
Thematernal obesity-related traits hypothesized to cause increased or
decreased fetal growth, based on observational associations with birth
weight: bodymass index (BMI)1; fasting glucose5; gestational or type 2
diabetes32; triglycerides9; HDL-cholesterol8; systolic blood pressure10;
vitamin D status (as indicated by 25-hydroxyvitamin D, 25[OH]D level)11;
adiponectin.12
Research Original Investigation Maternal Obesity-Related Traits and BirthWeight–Genetics
1130 JAMA March 15, 2016 Volume 315, Number 11 (Reprinted) jama.com
Downloaded From: http://jama.jamanetwork.com/ by a Imperial College London User  on 09/15/2016
Copyright 2016 American Medical Association. All rights reserved.
traits measured in pregnancy and their sources are given in
eTable 4 in the Supplement. In each available study, linear re-
gressionof thematernal trait (eg,BMI)against thegenetic score
wasperformed, adjusting formaternal age.Toconfirmthat as-
sociations between each genetic score and its respective ma-
ternal traitwere similar in the same individuals during andaf-
ter pregnancy, available data were used from 2 longitudinal
studies (ALSPAC and the Exeter Family Study of Childhood
Health [EFSOCH]). To check that the strategy for SNP selec-
tion had resulted in genetic scores that were specific to each
maternal trait, the associationwas testedbetweeneachof the
8 genetic scores and eachmaternal trait in addition to indica-
tors of maternal socioeconomic status and smoking.
Analyses ofMaternal Obesity-Related Traits
and BirthWeight
ForBMI andeach relatedmaternal trait, 2mendelian random-
ization approaches were used to test the hypothesis that the
trait was causally related to birth weight. First, associations
weretestedbetweengeneticscores representingmaternal traits
andoffspringbirthweightusing themaximumnumberofpar-
ticipants (ie, for each trait, those with genetic score and off-
springbirthweightdataavailable, irrespectiveofwhether they
had the maternal trait measured). An association of the ge-
netic scorewith birthweight would support a possible causal
relationshipbetweenthe trait (eg,prepregnancyBMI)andbirth
weight but would not provide information on the size of that
association. Second,weperformedanalyses in thosewith the
measured trait that enabled an estimate of the size of a pos-
sible causal relationship. The analyses took into account the
associationbetween each genetic score and thematernal trait
it represented (eg, BMI), in addition to the association be-
tween the same genetic score and birth weight. These 2 re-
sults were used to calculate an association between the ma-
ternal trait (eg, BMI) and birth weight that was free from
confounding. This second approach measures the relation-
ship between variation inmaternal BMI (or BMI-related trait)
andbirthweight that is attributableonly togenetic factors (see
Figure 1 for an explanation of the method). For each ap-
proach, meta-analysis was used to combine data from indi-
vidual studies (see eMethods in the Supplement).
Usingthefirstapproach,weinvestigatedtheassociationbe-
tween each genetic score and (1) birthweight and (2) ponderal
index (an indexofneonatal leanness, calculatedasbirthweight
in kilograms divided by birth length in meters cubed). Within
each study, birth weight or ponderal index Z scores were re-
gressed against each maternal genetic score, adjusted for off-
spring sex and gestational age. Analyses using the type 2 dia-
betes genetic score were repeated after excluding participants
with preexisting and gestational diabetes. Analyses using the
SBP genetic score were repeated after excluding participants
with preeclampsia and existing or gestational hypertension.
The genetic estimate of the associationbetweeneachma-
ternal trait and birth weight or ponderal index from the sec-
ond approach was compared with the corresponding obser-
vational association. To obtain the observational estimates,
linear regression was performed using birth weight or pon-
deral index as the dependent variable, and each of 7maternal
traits as independent variables, adjusting for sex and gesta-
tionalage.Therewas insufficient informationonmaternal type
2 diabetes prevalence, so it was not possible to estimate the
causal relationship for that trait. Full details of the analysis are
provided in the eMethods (in the Supplement).
Maternal BMI, BirthWeight, and Fasting Glucose
To estimate how much of the association between maternal
BMI and birth weight might be mediated by fasting glucose,
available data were used first to estimate the approximate
causal relationship between a 1-SD higher maternal BMI
(≈4points) and (1) fastingglucoseand (2) SBP.Then,usingeach
of those estimates, the results of the mendelian randomiza-
tion analyses were rescaled to represent the effects of fasting
glucose and SBP that could be directly compared with the
causal relationship between a 1-SD higher maternal BMI and
birth weight (see eMethods in the Supplement for a detailed
description of the method).
Correcting for Direct Fetal Genotype Effects
Genotypesofmaternal-fetalpairswereavailable inupto8stud-
ies (total for analysis, 11 493). Analyses were repeated includ-
ing the fetal genotype at each SNP in themodel to correct for
potential confoundingcausedbydirecteffectsof the fetalgeno-
type. A 2-sided P value <.05 was considered to provide evi-
denceagainst thenull hypothesis. Statistical softwareused for
data analysiswithineach individual study isdetailed ineTable
2 in the Supplement. Allmeta-analyseswereperformedusing
Stata v.13 (StataCorp).
Figure 1. Principle ofMendelian Randomization
Maternal genetic risk score 
for the trait (eg, weighted 
score of 30 genetic variants 
associated with BMI)
Fetal genotype
Maternal trait (eg, BMI) Fetal growth (birth weight 
or ponderal index)
Confounding factors (eg, 
socioeconomic status)
w
y
x
z
If a maternal trait causally influences offspring birth weight, then a risk score of
genetic variants associated with that trait will also be associated with birth
weight. Because genotype is determined at conception, it should not be
associated with factors that normally confound the association between
maternal traits and birth weight (eg, socioeconomic status). Estimates of the
genetic score–maternal phenotype association (w) and the genetic score-birth
weight association (x) may be used to estimate the association between the
maternal trait variation that is due to genetic score and birth weight (y = x/w),
which is expected to be free from confounding. If the estimated causal
relationship, y, is different from the observational association between the
measuredmaternal phenotype and birth weight, this would suggest that the
observational association is confounded (assuming that the assumptions of the
mendelian randomization analyses are valid).14 The dashed line connecting
maternal trait with fetal growth indicates that the causal nature of the
association is uncertain. It is important to adjust for possible direct effects of
fetal genotype (z). Bodymass index is calculated as weight in kilograms divided
by height in meters squared; ponderal index of neonatal leanness, calculated as
birth weight in kilograms divided by birth length in meters cubed.
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Results
The characteristics of included participants from the 18 con-
tributing studies are shown inTable 1. Among the 30487new-
borns themeanbirthweight ranged from3325g to 3679g.The
meanprepregnancyBMIwasavailable in 11 studies and ranged
from22.78 to 24.83. Themeanmaternal age at delivery, avail-
able in 16 studies, ranged from 24.5 years to 31.5 years.
There was evidence of an association between each ge-
netic score and its corresponding maternal trait measured in
pregnancy (P ≤ .003; Table 2). For BMI, fasting glucose, and
SBP,data frommultiplestudiesweremeta-analyzed,withsimi-
lar effect estimates among studies for BMI and fasting glu-
cose (P for heterogeneity >.05) and evidence of heteroge-
neity for SBP (P for heterogeneity = .04). The effect sizes of
associations betweenmaternal traits and their respective ge-
netic scoreswere very similarwhen compared in the same in-
Table 1. Key Characteristics of Participants by Study
Sourcea Study Country
Offspring Years
of Birth
No. of
Women With
Birth Weight
for ≥1 Child
No. of
Offspring With
Genotype
Mean (SD)
Maternal Age
at Delivery, y
Maternal
Prepregnancy
BMI
Offspring Birth
Weight, g
Fraser et al,33
2013
ALSPAC United
Kingdom
1991-1992 7304 4913 28.5 (4.8) 22.93 (3.73) 3481 (475)
Schlemm
et al,34 2010
BBC Germany 2000-2004 1357 1357 30.1 (5.4) 22.78 (3.93) 3472 (511)
Power and
Elliott,35 2006
B58C-WTCCC United
Kingdom
1972-2000 855 NA 26.2 (5.2) NA 3325 (483)
Power and
Elliott,35 2006
B58C-T1DGC United
Kingdom
1972-2000 836 NA 26.1 (5.4) NA 3379 (469)
Zhao H et al,36
2009
CHOP United States 1987-Present 312 NA NA NA 3440 (562)
Bisgaard,37
2004
COPSAC-2000 Denmark 1998-2001 282 282 30.4 (4.3) NA 3560 (505)
Nohr et al,38
2009
DNBC-GOYA Denmark 1996-2002 1805 NA 29.2 (4.2) 23.57 (4.27) 3643 (495)
Olsen et al,39
2001
DNBC-PTB-CONTROL Denmark 1987-2009 1649 975 29.9 (4.2) 23.57 (4.27) 3595 (497)
Knight et al,40 EFSOCH United
Kingdom
2000-2004 746 332b 30.5 (5.3) 24.07 (4.42) 3512 (480)
Lacroix et al,41
2013
GEN-3G Canada 2010-2013 676 NA 28.4 (4.4) 24.83 (5.63) 3448 (433)
Jaddoe et al, 42
2012
Generation R The
Netherlands
2002-2006 3810 2196 31.2 (4.5)c 23.12 (3.92) 3528 (494)
Metzger et al,5
2008 (GWAS)d
HAPO United
Kingdom,
Canada,
Australia
2000-2006 1380 1300 31.5(5.3)c 24.5 (5.0) 3557 (517)
Metzger et al,5
2008
(non-GWAS)d
HAPO United States,
United
Kingdom,
Canada,
Australia
2000-2006 3590 2318 30.4 (5.4)c 24.63 (5.33) 3526 (463)
Mangus
et al,43 2006
MoBa Norway 1999-2008 650 350 28.5 (3.3) 23.93 (3.94) 3679 (430)
Rantakallio,44
1969
NFBC1966 Finland 1987-2001 2035 NA 26.5 (3.7) NA 3525 (461)
Boomsma
et al,45 2006
NTR The
Netherlands
1946-2003 706 NA 27.1 (3.7) NA 3469 (529)
Medland et
al,46 2009
QIMR Australia 1929-1990 892 NA 24.5 (4.0) 22.79 (5.13) 3344 (532)
Naiatteru
et al,47 2013;
Moayyeri
et al,48 2013
TwinsUK United
Kingdom
NA 1602 NA NA NA 3365 (581)
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children;
BBC, Berlin Birth Cohort; B58C-WTCCC, 1958 British Birth Cohort-Wellcome
Trust Case Control Consortium; B58C-T1DGC, 1958 British Birth Cohort-Type 1
Diabetes Genetics Consortium; CHOP, Children’s Hospital of Philadelphia;
DNBC-GOYA, Danish National Birth Cohort-Genetics of Obesity
in Young Adults study; DNBC-PTB-CONTROLS, Danish National Birth
Cohort Preterm Birth; EFSOCH, Exeter Family Study of Childhood Health;
GEN-3G, Genetics of Glycemic Regulation in Gestation and Growth;
HAPO, Hyperglycemia and Adverse Pregnancy Outcome; MoBa, the Norwegian
Mother and Baby Cohort; NA, not available; NFBC1966, the Northern Finland
1966 Birth Cohort; NTR, Netherlands Twin Registry; QIMR, Queensland Institute
of Medical Research.
a For full details, see eTable 1 in the Supplement.
b Fetal genotype in EFSOCH available only for the fasting glucose genetic score.
c In Generation R, maternal age was recorded, on average, at 14.4 weeks of
gestation; in HAPO, maternal age was recorded, on average, at 28 weeks
of gestation.
dGenome-wide association study.
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dividuals during and outside pregnancy, with the exception
of theSBPgenetic score,whichhadaweakereffectduringpreg-
nancy (eTable 5 in the Supplement). There was no evidence
of association between any genetic score andpotentially con-
founding variables. No individual genetic score was associ-
ated with any of the other maternal traits, except for the ge-
netic score for BMI,whichwas positively associatedwith SBP
(P < .003 Bonferroni-corrected for 15 tests; eTable 6 in the
Supplement).
HigherMaternal BMI and Higher BirthWeight
The maternal BMI genetic score was associated with higher
birth weight (Table 3) and ponderal index (eTable 7 in the
Supplement) with similar effect sizes before and after adjust-
ing forpossibleeffectsof fetalgenotype.Using thegenetic score
to quantify the possible causal association, a 1-SD genetically
higher maternal BMI was associated with a 55-g higher off-
spring birth weight (95% CI, 17-93 g). After adjusting for fetal
genotype, the estimated effect was 104-g increase (95% CI,
32-176g) (Table4). Thesemendelian randomization causal es-
timates were similar to the observational association of 62 g
per SD of higher maternal BMI (95% CI, 56-70 g) (Figure 2).
Similar resultswereobtained forponderal index (eTable8 and
eFigure 1 in the Supplement).
HigherMaternal Fasting Glucose, Higher BirthWeight
The maternal fasting glucose and type 2 diabetes genetic
scores were associated with higher birth weight (Table 3) and
ponderal index (eTable 7 in the Supplement) with similar
effect size estimates before and after adjusting for fetal geno-
type and before and after excluding preexisting and gesta-
tional diabetes. Using the genetic score to estimate the pos-
sible causal relationship, a 1-SD (7.2 mg/dL) of genetically
higher maternal glucose was associated with a 114-g higher
birth weight (95% CI, 80-147 g). After adjusting for fetal geno-
type, the association was 145 g (95% CI, 91-199 g) (Table 4).
These genetic estimates were similar to the observational
association of 92 g (95% CI, 80-104) per each SD higher
maternal glucose (7.2 mg/dL) (Figure 2). Similar results were
obtained for ponderal index (eTable 8 and eFigure 1 in the
Supplement).(To convert glucose from mg/dL to mmol/L,
multiply by 0.0555.)
Table 2. Associations BetweenMaternal Genetic Scores andMaternal Obesity-Related Traits
Sourcea
No. of
Studies
Maternal
Obesity-Related
Trait
No. of
SNPs
for
Genetic
Score
Estimate of %
Variance
Expalined by
Genetic Score
in Pregnant
Womenb
No. of Women
With Traits
Measured During
Pregnancyc
Estimated Change in Maternal
Trait per Average Weighted
Trait-Raising or Lowering
(95% CI)d P Value
P for
Heterogeneitye I2,%
Speliotes
et al,49 2010
5 Prepregnancy
BMI
30 1.8, ALSPAC 11 822 0.145 (0.126 to 0.164) <2 × 10−16 .18 35.8
Dupuis
et al,50 2010
3 Higher fasting
glucose mg/dLf
13 5, EFSOCH 5402 0.52 (0.45-0.58) <2 × 10−16 .70 0
Morris
et al,51 2012
1 Higher
gestational and
existing
diabetes, mg/dL
55 1.4, ALSPAC 6606g OR, 1.08 (1.03 to 1.14) .003
Teslovich
et al,52 2010
1 Higher
triglycerides,
mg/dL
17 3, EFSOCH 663 4.9 (2.8 to 6.9) 3 × 10−6
Teslovich
et al,52 2010
1 Lower HDL-C,
mg/dL
4 3, EFSOCH 733 −1.9 (−2.8 to −1.0) 1 × 10−5
Ehret et al,53
2010
2 Higher SBP
mm Hg
33 1, ALSPAC 8450 0.186 (0.140 to 0.231) <2 × 10−16 .04 76.0
Vimaleswaran
et al,6 2013
1 Lower
vitamin D, log
transformedh
2 0.2, ALSPAC 4767 −0.024 (−0.039 to −0.009) .002
Yaghootkar
et al,54 2013
1 Lower
adiponectin, log
transformed
3 2,HAPO 1376 −0.17 (−0.23 to −0.11) 1 × 10−8
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children3; BMI,
bodymass index, calculated as weight in kilograms divided by height in meters
squared; EFSOCH, Exeter Family Study of Childhood Health40; HAPO,
Hyperglycemia and Adverse Pregnancy Outcome study5; HDL-C, high-density
lipoprotein cholesterol; OR, odds ratio; SBP, systolic blood pressure; SNP,
single-nucleotide polymorphism.
SI conversion factors: to convert glucose frommg/dL tommol/L, multiply by
0.0555; HDL-C frommg/dL tommol/L, 0.0259; triglycerides frommg/dL to
mmol/L, 0.0113.
a Genome-wide association studies that originally identified the SNPs used in
the genetic scores (studies of nonpregnant individuals).
b To estimate the variance in each trait explained by its respective genetic score
in pregnant women, the largest available study was used. Further details about
the included studies can be found in eTable 4 in the Supplement.
c Except BMI, for which the appropriate measurement is before pregnancy.
d Estimated change in maternal trait per unit change in the genetic score. The
genetic score for eachmaternal trait was modeled according to its known
direction of association with higher BMI (see column 4, above, and the Box).
e Evidence of heterogeneity among studies was estimated whenmore than 1
study contributed to the analysis.
f Removing the 1 study in which the rs10830963 SNPwas poorly imputed
(r2 < 0.8), we obtained very similar results (n = 4026; effect size = 0.028
(95% CI, 0.024-0.032); P < 2 × 10−16; P for heterogeneity = 0.46; I2 = 0%).
g Fifty-four cases, 6552 controls.
h The 2 SNPs selected for the vitamin D genetic score have a hypothesized role
in the synthesis of vitamin D (as opposed to its metabolism) and are
recommended for use in mendelian randomization studies.16,17
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Maternal Lipids, Adiponectin, and BirthWeight
The maternal triglyceride genetic score was not associated
with offspring birth weight (Table 3) or ponderal index
(eTable 7 in the Supplement). Using the genetic score to esti-
mate the possible causal relationship, a genetically higher
maternal triglyceride level was not associated with offspring
birth weight and the 95% CIs around the genetic estimate
excluded the observational association between maternal
triglycerides and birth weight (P = .007 testing difference
between genetic and observational association; Table 4;
Figure 2). Likewise, the genetic estimate of the possible
effect of maternal adiponectin levels on offspring birth
weight was different from the observational association
(P = .002). The genetic score for HDL-C was not associated
with birth weight or ponderal index. The analysis was con-
sistent with no causal relationship; however, this could not
be distinguished from the negative observational association
between maternal HDL-C and birth weight.
Higher SBP and Lower BirthWeight
ThematernalSBPgenetic scorewasassociatedwith lowerbirth
weight (Table 3) and ponderal index (eTable 7 in the Supple-
ment) with similar effect-size estimates before and after ad-
justing for fetal genotype and before and after excludingma-
ternal preeclampsia andhypertension.Using thegenetic score
to estimate thepossible causal relationship, a 1-SD (10mmHg)
genetically highermaternal SBPwas associatedwith a−208-g
lower offspring birthweight (95%CI, −394 to −21 g). After ad-
justing for fetal genotype, theestimatedeffectwas−151 g (95%
CI, −390 to 89 g) (Table 4). The genetic estimate of the asso-
ciation between maternal SBP and birth weight in the full
sample of women was in the opposite direction to the obser-
vational association (P = .01 fordifferencebetweengeneticand
observational associations; Table 4; Figure 2). Similar results
were obtained for ponderal index (eTable 8 and eFigure 1 in
the Supplement).
Thematernal genetic score for lower vitaminD statuswas
associated with lower birth weight (P = .03; Table 3). How-
ever, the estimated causal relationship was not significantly
different from0(theestimatedchange inbirthweight fora 10%
genetically lower maternal 25[OH]D level was −26 g (95% CI,
−54 to 2 g); Table 4, Figure 2).
Consistency Among Studies in theMeta-analysis
Associations between maternal genetic scores and offspring
birth weight were similar between studies in the meta-
analysis (Table 3; P for heterogeneity>.05). When data were
combined from observational analyses, the associations be-
tweenmaternal fasting glucose or SBP and birth weight were
similar (P for heterogeneity>.05), and there was evidence of
heterogeneity for theBMI-birthweight observational associa-
tion (Table 4; P for heterogeneity = .03).
Maternal BMI, Maternal Fasting Glucose,
and Offspring BirthWeight
To estimate how much of the association between maternal
BMI and birth weight might be mediated by fasting glucose,
the BMI and fasting glucose genetic scores were used. A 1-SDTa
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geneticallyhighermaternalBMIwasassociatedwitha0.34SD
( ≈ 2.5mg/dL)highermaternal fastingglucose. Fromthemen-
delian randomization analyses, a 1-SD genetically higherma-
ternal fasting glucosewas associatedwith a 114-g higher birth
weight (95%CI, 80-147 g). Consequently, itwaspredicted that
a 0.34-SD higher fasting glucose would be associated with a
114 g × 0.34 = 39g; (95%CI, 27-50g) higher birthweight. This
approximation is broadly similar to the total estimated effect
ofanSDhigherBMIonbirthweight (55g;95%CI, 17-93g).How-
ever, using the same method with the BMI and SBP genetic
scores, we estimated that a an SD highermaternal BMIwould
beassociatedwitha−40g(95%CI,−75to−4) lowerbirthweight
via its associationwithmaternal SBP (eFigure 2 in the Supple-
ment),whichwould oppose thepositive associationwithma-
ternal fasting glucose.
Discussion
This study provides evidence for a possible causal associa-
tion between maternal BMI and offspring birth weight. A
genetically higher maternal BMI of 4 points was associated
with a 55 g (95% CI, 17-93 g) higher offspring birth weight. In
addition, a genetically higher circulating maternal fasting
glucose of 7.2 mg/dL was associated with a 114 g (95% CI,
80-147 g) higher birth weight, whereas genetically higher
maternal SBP of 10 mm Hg was associated with a −208 g
(95% CI, −394 to −21 g) lower birth weight. These results pro-
vide evidence that genetically elevated maternal glucose and
SBP may have directionally opposite causal associations with
birth weight. The estimated associations between these
maternal traits and birth weight (either increased or reduced)
are substantial and of clinical importance. They support
efforts to maintain healthy gestational glucose and blood
pressure levels to ensure healthy fetal growth. The positive
association between maternal BMI and birth weight may be
partially mediated by the effect of higher BMI on circulating
maternal fasting glucose. There was no evidence of associa-
tion of offspring brith weight with a genetic score for mater-
nal triglycerides, which have also been hypothesized to be
important contributors to higher birth weight in overweight
or obese women. Other lipids, or specific subclasses of tri-
glycerides, might be important but require further study.
These results provide genetic evidence of a potentially
causalassociationbetweenmaternalglycemiaandbirthweight
andponderal index, even inwomenwithnopreexistingorges-
tational diabetes, which is consistent with published obser-
vational data.5 A possible explanation for this finding is that
womenwithahighergenetic score for type2diabeteshaverela-
tively higher glucose levels in pregnancy, as a result of inad-
equate beta-cell compensation in response to gestational in-
sulin resistance,19,20 leading to increased placental glucose
transfer and fetal insulin secretion,21 andconsequentlyhigher
birth weight.
Table 4. Observational and Genetic Associations Between EachMaternal Trait and Offspring BirthWeight
Study Used for
Observational
Estimatesa Maternal Trait
Value of
1-SD Change
in the Trait
With Units
No. of
Women for
Observational
Estimat
Observational
Estimate of the
Change in Birth
Weight, g, per 1-SD
Change in Maternal
Trait, (95% CI)b
Genetic Estimate of
the Change in Birth
Weight, g, per 1-SD
Change in Maternal
Trait (95% CI), gc P Valued
Genetic Estimate of
Change in Birth
Weight, g, per 1-SD
Change in Maternal
Trait(95% CI)e P Valued
ALSPAC EFSOCH,
HAPO
Higher
prepregnancy
BMI
4 points 11 969 62 (56 to 70) 55 (17 to 93) .70 104 (32 to 176) .28
EFSOCH
HAPO
Higher fasting
glucose
7.2 mg/dL 6008 92 (80 to 104) 114 (80 to 147) .28 145 (91 to 199) .09
EFSOCH Higher
triglycerides
61.9 mg/dL 930 32 (7 to 56) −24 (−55 to 8) .007 −33 (−86 to 20) .03
EFSOCH Lower HDL-C 19.3 mg/dL 927 30 (3 to 58) 0 (−33 to 34) .17 −1 (−55 to 54) .32
ALSPAC
HAPO
Lower SPB 10 mm Hg 12 077 24 (15 to 34) −208 (−394 to −21) .01 −151 (−390 to 89) .14
ALSPAC Lower
vitamin Db
10% 4710 −4 (−7 to −2) −26 (−54 to 2) .13 −56 (−112 to 1) .07
HAPO Lower
adiponectinb
10% 1376 14 (9 to 18) −1 (−9 to 7) .002 4 (−9 to 17) .19
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children33;
BMI, bodymass index, calculated as weight in kilograms divided by height in
meters squared; EFSOCH, Exeter Family Study of Childhood Health40; HAPO,
Hyperglycaemia and Adverse Pregnancy Outcomes5; HDL-C, high-density
lipoprotein cholesterol; SBP, systolic blood pressure.
SI conversion factors: to convert glucose frommg/dLmmol/L, multiply by
0.0555; HDL-C frommg/dL tommol/L, 0.0259; triglycerides frommg/dL to
mmol/L, 0.0113.
a Heterogeneity statistics from themeta-analyses of observational associations
were P = .03 and I2 = 67.7% for BMI; P = .09 and I2 = 59.1% for fasting glucose;
and P = .54 and I2 = 0% for SBP.
bNo. of women included in observational analyses. (No. of women and
offspring in genetic analyses is reported in Table 2 and Table 3.) Adjusted for
sex and gestational age.
c Estimated change in birth weight per SD (or 10%) change in maternal trait
(with sex and gestational age as covariates). Birth weight is adjusted for sex
and gestational age. Maternal trait is unadjusted for genotype. For 25[OH]D
and adiponectin, the estimated change in birth weight per 10% reduction in
maternal trait level is presented because these variables were logged for
analysis.
dP values, adjusted for fetal genotype, compare observational with genetic
birth weight associations. P values <.05 are considered to indicate evidence
that the genetic effect size estimate is different from the observational
estimate, suggesting that the observational estimate is subject to confounding
or bias.
e Estimated change in birth weight per SD (or 10%) genetic change in maternal
trait (with sex, gestational age, and fetal genotype as covariates). The No. of
offspring is the same as listed in Table 1 and Table 2.
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These data did not support a causal association between
maternal triglyceride, HDL-C or adiponectin levels and birth
weight or ponderal index. The genetic associations between
maternal triglycerides and adiponectin andbirthweightwere
null, in contrast to the observational associations, suggesting
that the observational associations seen herein, and in other
published studies,8,9,12 are confounded.
The mendelian randomization analysis showed that the
positive observational association between SBP and birth
weight is confounded,most likelybyBMI,which isbothan im-
portant risk factor for higher SBP in pregnancy and positively
associated with birth weight.1 Using genetic variants that are
independent of confounding by BMI, genetically higher ma-
ternal SBPwas associatedwith lower birth weight, even after
excludingpreeclampsiaandhypertension.Theprecisionofour
estimateof the change inbirthweightper 1 SD inmaternal SBP
could be affected by theheterogeneity between studies in the
genetic score-SBP association (P = .04, I2 = 76.0%; Table 2).
However, associationsbetween theSBPgenetic scoreandbirth
weight were consistent across all 13 meta-analyzed studies
(P = .14; I2 = 30.4%; Table 3) and supportive of a causal asso-
ciation between highermaternal SBP and lower birth weight.
These findingssupportobservationalassociationsbetweenma-
ternal SBPandbirthweight thatwereadjusted for awide range
of confounders22 andare consistentwith laboratoryandpopu-
lation studies suggesting a link between hypertensive disor-
ders of pregnancy and impaired fetal growth due to placental
pathology.23Thereare increasingconcernsabout theeffect the
obesity epidemicmight have on birth size, via greater mater-
nal BMI. However, the focus of that concern has been largely
Figure 2. Comparison of the ObservationalWith the Genetic Change in BirthWeight (in grams) for an SD Change
in EachMaternal Obesity-Related Trait
–400 0 300–100 200100
Estimated Difference in Body Weight, g
per 1-SD Change in Trait a
–200–300
1-Standard Deviation
Change in Trait aSource
Prepregnancy BMI
4 points higher
7.2 mg/dL higher
61.9 mg/dL higher
19.3 mg/dL lower
10 mm Hg higher
10% lower
10% lower
No. of
Studies
No. of
Women
No. of
Offspring
Genotypes
3 11 969 0Observational
16 25 265 0Genetic
7 10 964 10 964Genetic (adjusted for fetal genotype in subset)
Fasting glucose
2 6008 0Observational
15 23 902 0Genetic
8 11 493 11 493Genetic (adjusted for fetal genotype in subset)
Triglycerides
1 930 0Observational
15 24 985 0Genetic
6 11 031 11 031Genetic (adjusted for fetal genotype in subset)
HDL cholesterol
1 927 0Observational
15 22 167 0Genetic
6 9176 9176Genetic (adjusted for fetal genotype in subset)
Systolic blood pressure
2 12 077 0Observational
13 20 062 0Genetic
5 7790 7790Genetic (adjusted for fetal genotype in subset)
25(OH)D
1 4710 0Observational
18 30 340 0Genetic
3 9510 9510Genetic (adjusted for fetal genotype in subset)
Adiponectin
1 1376 0Observational
9 14 920 0Genetic
5 7820 7820Genetic (adjusted for fetal genotype in subset)
a For 25[OH]D and adiponectin, we present the change in birth weight for a
10% change in maternal trait level because these variables were logged for
analysis. The genetic change was estimated frommendelian randomization
analysis, in which a genetic score was used to estimate the possible causal
relationship between thematernal trait and birth weight. The genetic estimate
is presented twice: in the second case it was adjusted for fetal genotype using
a subset of available studies. The error bars represent the 95% CIs around
the effect size estimates. For maternal prepregnancy bodymass index
(BMI, calculated as weight in kilograms divided by height in meters squared)
and fasting glucose, the 95% CIs for both the observational and genetic
approaches exclude the null, suggesting positive possible causal relationships
betweenmaternal BMI and fasting glucose and birth weight. For maternal
systolic blood pressure, the observational analysis suggested a weak positive
association with birth weight, whereas the genetic analysis showed evidence
of a negative possible causal relationship. Observational analyses suggested
that higher maternal triglyceride levels, lower maternal adiponectin and lower
maternal high-density lipoprotein (HDL) cholesterol levels were associated
with higher birth weight, whereas lower maternal vitamin D status was
associated with lower birth weight, but none of these was supported by the
genetic analyses. To convert glucose frommg/dL tommol/L, multiply by
0.0555; HDL-C frommg/dL tommol/L, 0.0259; triglycerides frommg/dL to
mmol/L, 0.0113.
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on increased birth size as a result of greater maternal glucose
and other fetal nutrients. Our findings suggest that theremay
be opposing effects of maternal blood pressure and glucose.
Publishedmendelian randomizationanalysesprovideevi-
dence that higher BMI is causally associated with lower vita-
minDstatus,6 andevidence frommultipleobservational stud-
ies suggests that lowermaternal vitamin D is associated with
lower birth weight.11,24 Our analysis of the vitamin D genetic
score provided someevidence to support a possible causal as-
sociationwith birthweight, but this requires further explora-
tion in larger numbers of pregnancies.
Socioeconomic factorsandrelatedbehaviors suchassmok-
ing are key confounders of observational associations be-
tweenmaternal BMI (orBMI-related traits) andoffspringbirth
weight, sincetheyareassociatedwithbothvariables (seeeTable
9 in Supplement for a demonstration of these associations in
the ALSPAC study). The genetic scores used in our analyses
were not associatedwith socio-economic factors or smoking,
and this illustrates a key strength of the mendelian random-
ization approach: since genotypes are determined at concep-
tion, such confounding is avoided.
There are some limitations to this study. Despite at-
tempts tomaximize specificity of the genetic scores, we can-
not fully exclude thepossibility that the selected genetic vari-
ants actonmore thanonematernal trait.Althoughall available
information was used, there was limited power to detect as-
sociations between the genetic scores andother traits. For ex-
ample, the known association between BMI-associated vari-
ants and triglyceride levels was not detected.25 With the
potential forhigh-throughputmetabolomicstudiesandagrow-
ing public database of genetic associations,26-28 future stud-
ies will likely improve the specificity (for different lipid sub-
fractions) of selected genetic variants.
Despite the large sample in this study, statistical power to
detectpotentiallycausal relationshipswas limitedforsomema-
ternal traits (see eMethods and eTable 10 in Supplement for
powercalculations).The total sampleprovidedmore than99%
power to detect associations at P < .05 between birth weight
and genetic scores such as fasting glucose and systolic blood
pressure that explain at least 0.1% variance in birth weight.
However, larger samples (>80000) will be needed to confi-
dently detect or rule out the association with vitamin D sta-
tus suggestedbyourdata,or smallerpositiveornegativecausal
associations betweenmaternal triglycerides,HDL-Cor adipo-
nectin and birth weight.
Although adjusting for the fetal genetic scoreswasneces-
sary to separatematernal effects from the direct effects of ge-
netic variants in the fetus, this could introduce bias via asso-
ciation with paternal genotypes. Assortative mating for BMI
couldadditionally result inacorrelationbetweenmaternal and
paternal genotypes, leading to similar bias. However, a fa-
ther’s genetic scorewould only confound themendelian ran-
domization estimates if the father’s phenotype were related
to birth weight, and we found only very weak associations of
fathers BMI and related traits with offspring birth weight
(eTable 11 in Supplement). Another potential bias could be in-
duced by the use of the genetic score for SBP, which was de-
rived from a genome-wide association study of blood pres-
sure conditional on BMI. Because BMI is also associated with
birth weight, this could bias the results. However, similar re-
sultswereobtainedusinganalternative genetic score thatwas
unadjusted for BMI (eMethods).
Inmendelian randomizationanalysis, aweakstatistical as-
sociation between a genetic score and amaternal trait (due to
low variance explained or small sample size) has the poten-
tial to cause weak instrument bias toward the observational
results.29 The proportions of maternal trait variance ex-
plainedby thegenetic scores aremodest inour study (Table2).
However, the large overall sample size ensured that the pos-
sible causal associations identified are unlikely to be due to
weak instrument bias (see eMethods).
Our analyses assume thatmaternal BMI and related traits
are linearlyassociatedwithoffspringbirthweight.Wehavenot
tested for nonlinear associations which, in a mendelian ran-
domizationdesign,would requirevery largenumbers.30How-
ever, for maternal BMI, fasting glucose and SBP, there is ob-
servational evidence of such linear associations across the
distribution, with no evidence of threshold or curvilinear
associations.5,10,31
Conclusions
In this mendelian randomization study, genetically elevated
maternal BMI andblood glucose levelswere potentially caus-
ally associatedwithhigheroffspringbirthweight,whereas ge-
netically elevated maternal SBP was potentially causally re-
lated to lower birth weight. If replicated, these findings may
have implications for counseling and managing pregnancies
to avoid adverse weight-related birth outcomes.
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